Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 322

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes

Open access
Kimberlin, David W., Whitley, Richard J., Wan, Wen, Powell, Dwight A., Storch, Gregory, Ahmed, Amina, Palmer, April, Sánchez, Pablo J., Jacobs, Richard F., Bradley, John S., Robinson, Joan L., Shelton, Mark, Dennehy, Penelope H., Leach, Charles, Rathore, Mobeen, Abughali, Nazha, Wright, Peter, Frenkel, Lisa M., Brady, Rebecca C., Van Dyke, Russell, Weiner, Leonard B., Guzman-Cottrill, Judith, McCarthy, Carol A., Griffin, Jill, Jester, Penelope, Parker, Misty, Lakeman, Fred D., Kuo, Huichien, Lee, Choo Hyung, Cloud, Gretchen A. · 2011 · New England Journal of Medicine

Abstract

BACKGROUND: Poor neurodevelopmental outcomes and recurrences of cutaneous lesions remain unacceptably frequent among survivors of neonatal herpes simplex virus (HSV) disease. METHODS: We enrolled neonates with HSV disease in two parallel, identical, double-blind, placebo-controlled studies. Neonates with central nervous system (CNS) involvement were enrolled in one study, and neonates with skin, eye, and mouth involvement only were enrolled in the other. After completing a regimen of 14 to 21 days of parenteral acyclovir, the infants were randomly assigned to immediate acyclovir suppression (300 mg per square meter of body-surface area per dose orally, three times daily for 6 months) or placebo. Cutaneous recurrences were treated with open-label episodic therapy. RESULTS: A total of 74 neonates were enrolled--45 with CNS involvement and 29 with skin, eye, and mouth disease. The Mental Development Index of the Bayley Scales of Infant Development (in which scores range from 50 to 150, with a mean of 100 and with higher scores indicating better neurodevelopmental outcomes) was assessed in 28 of the 45 infants with CNS involvement (62%) at 12 months of age. After adjustment for covariates, infants with CNS involvement who had been randomly assigned to acyclovir suppression had significantly higher mean Bayley mental-development scores at 12 months than did infants randomly assigned to placebo (88.24 vs. 68.12, P=0.046). Overall, there was a trend toward more neutropenia in the acyclovir group than in the placebo group (P=0.09). CONCLUSIONS: Infants surviving neonatal HSV disease with CNS involvement had improved neurodevelopmental outcomes when they received suppressive therapy with oral acyclovir for 6 months. (Funded by the National Institute of Allergy and Infectious Diseases; CASG 103 and CASG 104 ClinicalTrials.gov numbers, NCT00031460 and NCT00031447, respectively.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1003509

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 322

Metadata

Authors
Kimberlin, D. W., Whitley, R. J., Wan, W., Powell, D. A., Storch, G., Ahmed, A., Palmer, A., Sánchez, P. J., Jacobs, R. F., Bradley, J. S., Robinson, J. L., Shelton, M., Dennehy, P. H., Leach, C., Rathore, M., Abughali, N., Wright, P., Frenkel, L. M., Brady, R. C., Van Dyke, R., Weiner, L. B., Guzman-Cottrill, J., McCarthy, C. A., Griffin, J., Jester, P., Parker, M., Lakeman, F. D., Kuo, H., Lee, C. H., & Cloud, G. A.
Venue
New England Journal of Medicine
Published
2011-10-06
Volume
365
Issue
14
Pages
1284-1292
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2151279983
Cited by
322
References
19
FWCI
19.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes. https://app.cochat.ai/papers/10.1056/nejmoa1003509
The paper
Kimberlin, D. W., Whitley, R. J., Wan, W., Powell, D. A., Storch, G., Ahmed, A., Palmer, A., Sánchez, P. J., Jacobs, R. F., Bradley, J. S., Robinson, J. L., Shelton, M., Dennehy, P. H., Leach, C., Rathore, M., Abughali, N., Wright, P., Frenkel, L. M., Brady, R. C., . . . Cloud, G. A. (2011). Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1003509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.